Human beta defensin 2 promotes intestinal wound healing in vitro

Journal of Cellular Biochemistry

Volumn 104, Issue 6, 2008, Pages 2286-2297

  Otte, Jan Michel ^a   Werner, Ilka ^a   Brand, Stephan ^b   Chromik, Ansgar M ^a   Schmitz, Frank ^a   Kleine, Michael ^c   Schmidt, Wolfgang E ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Planton GmbH   (Germany)

Author keywords

Crohn's disease; Human beta defensin 2; Inflammatory bowel disease; Intestinal barrier function; Wound healing

Indexed keywords

BETA DEFENSIN 2; BROXURIDINE; MUCIN 2; MUCIN 3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL STIMULATION; CELL STRAIN CACO 2; CELL STRAIN HT29; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENTERITIS; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SLOT BLOT HYBRIDIZATION; WOUND HEALING;

ACTINS; APOPTOSIS; BETA-DEFENSINS; CACO-2 CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETON; EPITHELIAL CELLS; HT29 CELLS; HUMANS; INTESTINES; MUCINS; RECEPTORS, CCR6; UP-REGULATION; WOUND HEALING;

EID: 49049103117     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21787     Document Type: Article

References (40)

1. Barlow PG, Li Y, Wilkinson TS, Bowdish DM, Lau YE, Cosseau C, Haslett C, Simpson AJ, Hancock RE, Davidson DJ. 2006. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol 80(3):509-520.
2. Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM. 2006. Implications of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130(7):1962-1974.
3. Bevins CL, Martin-Porter E, Ganz T. 1999. Defensins and innate host defence of the gastrointestinal tract. Gut 45(6):911-915.
4. Boman HG. 2000. Innate immunity and the normal microflora. Immunol Rev 173:5-16. Review
5. Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Goke B, Dambacher J. 2006a. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 97(4):709-7023.
6. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diepolder H, Marquardt A, Jagla W, Popp A, Leclair S, Herrmann K, Seiderer J, Ochsenkuhn T, Goke B, Auernhammer CJ, Dambacher J. 2006b. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290(4):G827-G838.
7. Dignass AU, Tsunekawa S, Podolsky DK. 1994. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 106(5):1254-1262.
8. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. 2004. Beta-defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol 137(2):379-385.
9. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Reinisch W, Teml A, Schwab M, Lichter P, Radlwimmer B, Stange EF. 2006. A chromosome 8 gene-cluster polymorphism with low human Beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79(3):439-448.
10. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van De venter S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG. 2001. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357(9272):1925-1928.
11. Hiemstra PS. 2006. Defensins and cathelicidins in inflammatory lung disease: Beyond antimicrobial activity. Biochem Soc Trans 34(Pt 2):276-278.
12. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411(6837):599-603.
13. Kao CY, Huang F, Chen Y, Thai P, Wachi S, Kim C, Tam L, Wu R. 2005. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J Immunol 175(10):6676-6685.
14. Lehrer RI. 2004. Primate defensins. Nat Rev Microbiol 2(9):727-738.
15. Liévin-Le Moal V, Servin AL. 2006. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: Mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 19(2):315-337.
16. Markeeva N, Lysovskiy I, Zhuravel E, Soldatkina M, Lyzogubov V, Usenko V, Potapov V, Pogrebnoy P. 2005. Involvement of human beta-defensin-2 in proliferation of transformed cells of human cervix. Exp Oncol 27(4):308-313.
17. Matsuzaki K, Sugishita K, Miyajima K. 1999. Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of gram-negative bacteria. FEBS Lett 449(2-3):221-224.
18. Nagaoka I, Tamura H, Hirata M. 2006. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2 X7. J Immunol 176(5):3044-3052.
19. Niyonsaba F, Iwabuchi K, Matsuda H, Ogawa H, Nagaoka I. 2002. Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol 14(4):421-426.
20. Niyonsaba F, Ogawa H, Nagaoka I. 2004. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111(3):273-281.
21. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411(6837):603-606.
22. Ogushi K, Wada A, Niidome T, Mori N, Oishi K, Nagatake T, Takahashi A, Asakura H, Makino S, Hojo H, Nakahara Y, Ohsaki M, Hatakeyama T, Aoyagi H, Kurazono H, Moss J, Hirayama T. 2001. Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells. J Biol Chem 276(32):30521-30526.
23. Ouellette AJ. 2004. Defensin-mediated innate immunity in the small intestine. Best Pract Res Clin Gastroenterol 18(2):405-419.
24. Podolsky DK. 1997. Healing the epithelium: Solving the problem from two sides. J Gastroenterol 32(1):122-126.
25. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118(2):229-241.
26. Sahly H, Schubert S, Harder J, Kleine M, Sandvang D, Ullmann U, Schroder JM, Podschun R. 2006. Activity of human beta-defensins 2 and 3 against ESBL-producing Klebsiella strains. J Antimicrob Chemother 57(3):562-565.
27. Shai Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462(1-2):55-70.
28. Shaykhiev R, Beisswenger C, Kandier K, Senske J, Puchner A, Damm T, Behr J, Bals R. 2005. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 289(5):L842-L848.
29. Soruri A, Grigat J, Forssmann U, Riggert J, Zwirner J. 2007. Beta-defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol 37(9):2474-2486.
30. Tokumaru S, Sayama K, Shirakata Y, Komatsuzawa H, Ouhara K, Hanakawa Y, Yahata Y, Dai X, Tohyama M, Nagai H, Yang L, Higashiyama S, Yoshimura A, Sugai M, Hashimoto K. 2005. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 175(7):4662-4668.
31. Tytgat KM, Buller HA, Opdam FJ, Kim YS, Einerhand AW, Dekker J. 1994. Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 107(5):1352-1363.
32. Tytgat KM, Bovelander FJ, Opdam FJ, Einerhand AW, Buller HA, Dekker J. 1995. Biosynthesis of rat MUC2 in colon and its analogy with human M UC2. Biochem J 309(1):221-229.
33. Tytgat KM, Opdam FJ, Einerhand AW, Buller HA, Dekker J. 1996. MUC2 is the prominent colonic mucin expressed in ulcerative colitis. Gut 38(4):554-563.
34. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Buller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. 2006. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131(1):117-129.
35. Wang J, Xi L, Hunt JL, Gooding W, Whiteside TL, Chen Z, Godfrey TE, Ferris RL. 2004. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 64(5):1861-1866.
36. Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschläger C, Feller AC, Stange EF. 2002. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 14(7):745-752.
37. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schroder JM, Stange EF. 2004. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: A novel effect of a probiotic bacterium. Infect Immun 72(10):5750-5758.
38. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H Jr, Fellermann K, Ganz T, Stange EF, Bevins CL. 2005a. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 102(50):18129-18134.
39. Wehkamp J, Fellermann K, Herrlinger KR, Bevins CL, Stange EF. 2005b. Mechanisms of disease: Defensins in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2(9):406-415.
40. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, Oppenheim JJ. 1999. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell C CR6. Science 286(5439):525-528.